Showing results (1061-1070 of 2,379) with videos related to
Sort By:
Pageof 238
Brain Sciences|November 25, 2023
Predictive Biomarkers of Treatment Response in Major Depressive DisorderLouise A Stolz, Jordan N Kohn, Sydney E Smith, et al.Translational Psychiatry|December 14, 2023
Pre-clinical indications of brain stimulation treatments for non-affective psychiatric disorders, a status updateLindsay L Benster, Cory R Weissman, Louise A Stolz, et al.Radiology|January 14, 2015
Relationship between Overall Survival of Patients with Non-Small Cell Lung Cancer and Whole-Body Metabolic Tumor Burden Seen on Postsurgical Fluorodeoxyglucose PET ImagesChenpeng Zhang, Chuanhong Liao, Bill C Penney, et al.AJOB Neuroscience|August 1, 2015
Ethical Issues in Deep Brain Stimulation Research for Treatment-Resistant Depression: Focus on Risk and ConsentLaura B Dunn, Paul E Holtzheimer, Jinger G Hoop, et al.Scientific Reports|July 29, 2020
Publisher Correction: Splice-specific deficiency of the PTSD-associated gene PAC1 leads to a paradoxical age-dependent stress behaviorJakob Biran, Michael Gliksberg, Ido Shirat, et al.Scientific Reports|June 14, 2020
Splice-specific deficiency of the PTSD-associated gene PAC1 leads to a paradoxical age-dependent stress behaviorJakob Biran, Michael Gliksberg, Ido Shirat, et al.Cancer|May 1, 1987
Mortality-associated factors in infected lymphoma patientsB S Shaikh, R D Moore, J J Tier, et al.Mededportal : the Journal of Teaching and Learning Resources|August 4, 2023
Climate Change as a Social Determinant of Health: An Interactive Case-Based Learning ActivityArindam Sarkar, Nital P Appelbaum, Rathi Asaithambi, et al.Blood|December 31, 2002
Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responsesHenry Y Li, Frederick R Appelbaum, Cheryl L Willman, et al.Leukemia Research|January 16, 2003
Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpressionD L Stirewalt, F R Appelbaum, C L Willman, et al.Pageof 238